An electrode system for an implantable cardioverter defibrillator. The electrode system includes a conductive structure which is physically and electrically connected to the housing or can of the implantable cardioverter defibrillator and is used as an electrode in combination with an existing implantable cardioverter defibrillator electrode or electrodes. The electrode system provides a therapeutically significant increase in the effective surface area of the implantable cardioverter defibrillator's electrodes without requiring an additional header connection, feedthru, or cable.
|
1. In an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, the combination with said cardioverter defibrillator pulse generator of a conductive tail electrode physically connected to said exterior surface of said housing, said tail electrode having a predetermined surface area, said tail electrode further having a length of 2-30 cm. and a diameter of 0.5-10 mm.
11. In an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, said housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry, the combination with said cardioverter defibrillator pulse generator of a conductive tail electrode physically connected to said exterior surface of said housing, said tail electrode having a first predetermined surface area, said tail electrode further having a length of 2-30 cm. and a diameter of 0.5-10 mm., and said tail electrode being electrically connected to said housing exterior surface, whereby said housing exterior surface and said tail electrode cooperate to yield a composite electrode surface area of a second predetermined surface area.
12. A pulse generator for use in an implantable cardioverter defibrillator system having at least one externally connected electrode, comprising:
(a) pulse generation circuitry; (b) a housing having an exterior surface, an interior surface defining a sealed interior space containing said pulse generation circuitry, and means, disposed on said exterior surface, to connect an external electrode to said pulse generation circuitry, said housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry; (c) a metallic, conductive connection tube welded to said housing; and (d) an elongated, flexible conductive tail electrode of a predetermined length connected to said exterior surface of said housing via said connection tube, said tail electrode having a first predetermined surface area, said tail electrode further having a length of 10-20 cm and a diameter of 1.0-5.0 mm., said tail electrode further being electrically connected to said housing exterior surface, whereby said housing exterior surface and said tail electrode cooperate to yield a composite electrode surface area of a second, greater, predetermined surface area.
2. The implantable cardioverter defibrillator pulse generator of
3. The implantable cardioverter defibrillator pulse generator of
4. The implantable cardioverter defibrillator pulse generator of
5. The implantable cardioverter defibrillator pulse generator of
6. The implantable cardioverter defibrillator pulse generator of
7. The implantable cardioverter defibrillator pulse generator of
8. The implantable cardioverter defibrillator pulse generator of
9. The implantable cardioverter defibrillator pulse generator of
10. The implantable cardioverter defibrillator pulse generator of
|
1. Field of the Invention
This invention relates to medical devices, and more particularly to implantable cardioverter defibrillators (ICD) used to cardiovert and/or defibrillate a human being. The ICD pulse generator kite-tail electrode system of this invention improves the performance of ICDs.
2. Background Information
The implantable cardioverter defibrillator is a well established therapy for malignant ventricular arrhythmia. The ICD senses an arrhythmia, stores a charge in an internal capacitor, and delivers that charge to the heart through electrodes.
An early form of electrodes are epicardial or pericardial patches which are sewn to the surface of the heart. Electrodes of this type are shown in FIG. 1. Epicardial or pericardial patch electrodes are disclosed in U.S. Pat. No. 4,821,723 to Baker, Jr. et al. and U.S. Pat. No. 4,827,932 to Ideker, et al. Another well know form of electrodes are endocardial lead electrodes which traverse the patient's vasculature and are disposed within the heart, preferably the right ventricle. A hybrid system uses endocardial leads in conjunction with epicardial patches. This system is disclosed in U.S. Pat. No. 4,548,203 to Tacker, Jr. et al. and U.S. Pat. No. 4,641,656 to Smits.
Most electrode systems which utilize epicardial patches require open chest surgery for implantation and positioning. Such surgery is traumatic, risky, expensive and requires a long patient recovery period. Referring to FIG. 2, procedures were therefore developed to subcutaneously implant a patch electrode in the left side of the patents chest or in the back under the shoulder blade. U.S. Pat. No. 4,662,377 to Hileman et al. teaches such a method. U.S. Pat. No. 4,727,877 to Kallock and U.S. Pat. No. 5,014,696 to Mehra disclose a similar method wherein a rigid plate is used in place of a patch. The advantage of these subcutaneous implantation methods is that major surgery is avoided, while at the same time improved performance is provided by the combination of the large surface area electrode element with the endocardial lead electrode.
Another approach used is to pericardially implant an electrode. In such systems, an electrode is implanted near the epicardial surface of the heart via an insertion through a small incision or an introducer apparatus. The electrodes simulate the epicardial electrodes, but avoid the trauma of open chest surgery. Pericardial electrodes and methods are disclosed in U.S. Pat. No. 4,860,769 to Fogarty et al. and U.S. Pat. No. 4,991,578 to Cohen.
Referring to FIG. 3, a recent development in ICD electrodes is the "pitchfork electrode" disclosed in U.S. Pat. No. 5,203,348 to Dahl, et al. This approach replaces the large surface area of the subcutaneous patch style electrode comprising three parallel wires forced about the patient's left side. Although the surface area of the electrodes is not great, the convex hull "outline" or "shadow" formed by the wires is large. This technique results in a very low impedance and also low defibrillation energy thresholds. Unfortunately, the implantation technique is complex and time consuming. Also, the low impedance is not consistent with the modem trend toward smaller ICD capacitance's which show the most benefit with high impedance.
Referring to FIG. 4, another recent electrode system approach is to use the housing or can of the ICD pulse generator as an electrode in conjunction with an endocardial lead electrode. This technique is shown in published European Patent Application 0453761A1 and in U.S. Pat. No. 5,133,353 to Hauser, U.S. Pat. No. 5,261,400 to Bardy and in U.S. Pat. No. 5,376,103 to Anderson. This approach, although it has advantages, is inconsistent with another trend in ICD design, namely that toward smaller ICD housing. Smaller housings will reduce the effective size of the electrode formed thereby, which will yield reduced performance. Anderson teaches the use of a subcutaneous electrode in conjunction with the ICD housing electrode, but this technique requires the addition of an external connection to the housing and the attendant complication of connectors, feedthrus, and cables, as well as the resultant increase in size of the housing, to accommodate the connector and feedthru.
Despite the need in the art for a safe, easy to implant, effective, and reliable electrode system for use with an ICD, and which overcomes the disadvantages, shortcomings and limitations of the prior art, none insofar as is known has been developed or proposed.
Accordingly, it is an object of the present invention to provide a new electrode system for use with an ICD. It is a further object of this invention to provide an electrode system which is safe, easy to implant, reliable and effective, and which overcomes the limitations and shortcomings of the prior art.
The present invention provides an electrode system for an implantable cardioverter defibrillator, including a conductive structure which is physically and electrically connected to the housing or can of the implantable cardioverter defibrillator and is used as an electrode in combination with an existing implantable cardioverter defibrillator electrode or electrodes. The electrode system provides a significant increase in the effective surface area of the implantable cardioverter defibrillator's electrodes.
In a basic aspect, the invention includes an implantable cardioverter defibrillator pulse generator including a housing having an exterior surface, an interior surface defining a sealed interior space containing pulse generation circuitry, and means, disposed on the exterior surface, to connect an external electrode to the pulse generation circuitry, wherein the improvement comprises, a conductive tail electrode physically connected to the exterior surface of the housing, the tail electrode having a predetermined surface area.
In a preferred embodiment, the invention yields a pulse generator for use in an implantable cardioverter defibrillator system having at least one externally connected electrode, comprising:
(a) pulse generation circuitry;
(b) a housing having an exterior surface, an interior surface defining a sealed interior space containing the pulse generation circuitry, and means, disposed on the exterior surface, to connect an external electrode to the pulse generation circuitry, the housing exterior surface comprising a conductive, metallic portion which is electrically connected to the pulse generation circuitry;
(c) a metallic, conductive connection tube connected to the housing; and
(d) an elongated, flexible conductive tail electrode of a predetermined length connected to the exterior surface of the housing via the connection robe, the tail electrode having a first predetermined surface area, the tail electrode further being electrically connected to the housing exterior surface, whereby the housing exterior surface and the tail electrode cooperate to yield a composite electrode surface area of a second, greater, predetermined surface area.
The features, benefits and objects of this invention will become clear to those skilled in the art by reference to the following description, claims and drawings.
FIG. 1 illustrates the prior art ICD electrode system having at least one epicardial patch electrode attached directly to the heart.
FIG. 2 illustrates the prior art ICD electrode system having an epicardial patch electrode and an endocardial lead electrode disposed within a chamber of the heart.
FIG. 3 illustrates the prior art ICD electrode system having a subcutanteously implanted "pitchfork" style electrode in combination with an endocardial lead electrode.
FIG. 4 illustrates the prior art ICD electrode system wherein the housing of the ICD pulse generator is utilized as an electrode in combination with an endocardial lead electrode.
FIG. 5 illustrates the ICD electrode system of the present invention, one embodiment of which comprises a kite-tail member attached to a pulse generator and working in combination with an endocardial lead electrode.
FIG. 6 is a plan view of an embodiment of the ICD electrode system of this invention.
FIG. 7 is a detailed view of an embodiment of the ICD electrode system of this invention.
The implantable cardioverter defibrillator is an important tool for managing the health of patients who have a history of heart problems. The ICD effects defibrillation of the human heart by passing a current through the heart for a predetermined time period. A voltage is generated in the ICD pulse generator and transmitted to the heart through electrodes. To successfully defibrillate an exemplary heart with a given set of electrodes, a current of approximately 6-11.5 A is required to produce a pulse width of 13-2 ms., respectively.
The present invention provides an electrode system for an implantable cardioverter defibrillator. Referring to FIG. 5, the ICD electrode system 10 of the present invention basically comprises an implantable pulse generator 11, an endocardial lead 12 connected to the pulse generator 11 via connection ports, and a kite-tail electrode 13 connected directly to the housing of the pulse generator 11.
The ICD pulse generator 11 is a sealed, canister-like unit which is implanted in the patient's body 14 and contains various electronic components. Implantation is made subcutaneously in the left chest area of the patient 14. The internal components (not shown) of the pulse generator 11 comprise a battery, charge storage means, preferably one or more capacitors, connected to the battery, electrode connection means connectable to the charge storage means and connected to the electrodes when in an operative orientation, and switch means connected to the charge storage means and to the electrode connection means for controlling the delivery of a high voltage defibrillation pulse, of a predetermined polarity, to the patient 14. The aforementioned internally disposed electrical components are well known in the art.
The endocardial lead electrode 12 is of a design which is known in the art. The electrode 12 extends from the implanted pulse generator canister 11 through the vascular system of the patient 14 to the heart 15. The endocardial lead electrode 12 preferably comprises at least two metallic or semi-metallic electrode members which are disposed in the chamber(s) of the heart 15. The electrode members typically are formed of coiled metal bands. Each electrode member is connected to an elongated conductive lead or wire. The leads are encased in a non-conductive sheath. The leads terminate in connectors which are attached to the pulse generator 11.
FIG. 6 shows a preferred embodiment of the pulse generator 11. The pulse generator 11 has a housing or can 19 which has a hollow interior for containing the aforementioned electrical components. The housing 19 may be oval, rectangular or irregularly shaped and is constructed of a non-reactive metal, preferably titanium. A header 20, preferably constructed of a polymeric material or non-reactive metal, is sealingly disposed at the top of the housing 19. The header 20 has a pair of electrode connectors 21 a and b. The electrode connectors 21 a and b are connectable, as is known in the art, to the endocardial lead electrode connectors located at the terminal end of the endocardial lead electrode leads. The connectors 21 a and b are connected to conductive leads which extend through apertures (not shown) in the header 21 into the interior of the pulse generator 11, where they are communicatively connected to the circuit components thereof The apertures are designed with known feedthru structures which seal and isolate the pulse generator 11 interior from the patient. Although the pulse generator 11 is preferably of the type wherein the metal housing 19 functions as an electrode in the ICD system 10, in conjunction with the endocardial electrode 12 or any other electrode or electrodes, it is within the purview of the invention that the housing not function as an electrode.
The kite tail electrode 22 is a thin, elongated structure of a predetermined length with proximal and distal ends 23 and 24, respectively. The tail electrode 22 has a length of 2-30 cm., and preferably 10-20 cm. The electrode 22 is constructed of metallic wire or cable, preferably composed of titanium, MP35N, stainless steel, or platinum. The overall diameter of the tail electrode 22 is 0.5-10 mm. A 1.0-5 mm diameters is preferred as a best compromise between compactness and strength.
Referring also to FIG. 7, a connection tube 25 with one closed end 26 and an open end 27 with a circumferential, low profile flange 32 is disposed on the exterior surface 29 of the can 19. The connection tube 25 is preferably constructed of titanium and has an inside diameter and depth sufficient to allow insertion of the tail electrode 22 proximal end 23 therein. The closed end 26 of the flanged tube 25 is inserted and the flange 32 is welded 30 at an aperture 28 in the titanium can 19 at a predetermined point, for example the edge opposite the header 20.
The proximal end 23 of the electrode 22 is inserted into the open, flanged end 27 of the connection tube 25. The connection tube 25 is then crimped interiorly to hold the electrode 22 in place. The crimped tube connector structure 25 maintains the hermetic seal between inside 31 and outside 29 surfaces of the pulse generator 11. If removal of the electrode tail 22 is required, for any reason, it may easily be cut loose, or in the alternative, freed by a sharp tug on the electrode tail 22. Full withdrawal of the electrode tail 22 from the patient body 14 may then be easily accomplished. After withdrawal of the electrode tail 22, a smooth non-irritating surface remains on the can 19. Importantly, the hermeticity of the interior 31 of the pulse generator 11 is maintained without the use of additional feedthru mechanism.
In one alternative embodiment, the welded flange tube is reusable to allow the removal of the tail or substitution of various tail lengths. In another alternative embodiment, the distal end of the kite tail electrode 22 may additionally have either molded tines or a molded tie-down section to firmly fixate the distal end of the electrode. Such fixation prevents any wandering of the electrode from its inserted, tested position. In yet another alternative embodiment, the electrode tail can be inserted or extracted repeatedly. The device has a terminal block in the header that is tied to the housing of the pulse generator. Fixation of the electrode tail to the block is made via a set screw or a similar positive locking mechanism.
In summary, the kite-tail electrode 22 is a conductive structure which is physically and electrically connected to the exterior of the housing 19 of the pulse generator 11 of the implantable cardioverter defibrillator 10 and is used as an electrode in combination with the endocardial lead electrode 12 and/or other electrodes. This electrode 22 provides a significant increase in the overall effective electrode surface area of the ICD system 10. The increased electrode surface area is believed to be therapeutically significant. Importantly, the electrode of this invention utilizes a direct metallic and conductive extension of the can or housing, and hermeticity is maintained with no connection through the header assembly and associated feedthru devices.
As many changes are possible to the embodiments of this invention utilizing the teachings thereof, the descriptions above, and the accompanying drawings should be interpreted in the illustrative and not the limited sense.
Kroll, Mark W., Adams, Theodore P., Nelson, Randall S.
Patent | Priority | Assignee | Title |
10016609, | Feb 07 2007 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
10052487, | Jan 25 2005 | Cameron Health, Inc. | Methods and devices for adapting charge initiation for an implantable defibrillator |
10183171, | May 29 2003 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
10575740, | May 26 2006 | CAMERON HEALTH INC. | Systems and methods for sensing vector selection in an implantable medical device |
11020602, | May 29 2003 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
11083897, | Jan 25 2005 | Cameron Health, Inc. | Methods and devices for adapting charge initiation for an implantable defibrillator |
5709709, | Feb 13 1996 | Angeion Corporation | ICD with rate-responsive pacing |
5814076, | Feb 09 1996 | SIRROM CAPITAL CORPORATION | Apparatus for improved cardiac pacing and sensing using extracardiac indifferent electrode configurations |
6091989, | Apr 08 1998 | Imperception, Incorporated | Method and apparatus for reduction of pain from electric shock therapies |
6721597, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous only implantable cardioverter defibrillator and optional pacer |
6754528, | Nov 21 2001 | CAMERON HEALTH, INC | Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator |
6778860, | Nov 05 2001 | CAMERON HEALTH, INC | Switched capacitor defibrillation circuit |
6834204, | Nov 05 2001 | CAMERON HEALTH, INC | Method and apparatus for inducing defibrillation in a patient using a T-shock waveform |
6856835, | Sep 18 2000 | CAMERON HEALTH, INC | Biphasic waveform for anti-tachycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
6866044, | Sep 18 2000 | CAMERON HEALTH, INC | Method of insertion and implantation of implantable cardioverter-defibrillator canisters |
6937907, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous electrode for transthoracic conduction with low-profile installation appendage and method of doing same |
6950705, | Sep 18 2000 | CAMERON HEALTH, INC | Canister designs for implantable cardioverter-defibrillators |
6952610, | Sep 18 2000 | CAMERON HEALTH, INC | Current waveforms for anti-tachycardia pacing for a subcutaneous implantable cardioverter- defibrillator |
6988003, | Sep 18 2000 | CAMERON HEALTH, INC | Implantable cardioverter-defibrillator having two spaced apart shocking electrodes on housing |
7039459, | Sep 18 2000 | CAMERON HEALTH, INC | Cardioverter-defibrillator having a focused shocking area and orientation thereof |
7039465, | Sep 18 2000 | CAMERON HEALTH, INC | Ceramics and/or other material insulated shell for active and non-active S-ICD can |
7043299, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead |
7062329, | Oct 04 2002 | CAMERON HEALTH, INC | Implantable cardiac system with a selectable active housing |
7065407, | Sep 18 2000 | CAMERON HEALTH, INC | Duckbill-shaped implantable cardioverter-defibrillator canister and method of use |
7065410, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous electrode with improved contact shape for transthorasic conduction |
7069080, | Sep 18 2000 | CAMERON HEALTH, INC | Active housing and subcutaneous electrode cardioversion/defibrillating system |
7076294, | Sep 18 2000 | Cameron Health, Inc. | Method of implanting ICD and subcutaneous lead |
7076296, | Sep 18 2000 | CAMERON HEALTH, INC | Method of supplying energy to subcutaneous cardioverter-defibrillator and pacer |
7090682, | Sep 18 2000 | CAMERON HEALTH, INC | Method and apparatus for extraction of a subcutaneous electrode |
7092754, | Sep 18 2000 | CAMERON HEALTH, INC | Monophasic waveform for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
7120495, | Sep 18 2000 | CAMERON HEALTH, INC | Flexible subcutaneous implantable cardioverter-defibrillator |
7120496, | Sep 18 2000 | Cameron Health, Inc. | Radian curve shaped implantable cardioverter-defibrillator canister |
7146212, | Sep 18 2000 | CAMERON HEALTH, INC | Anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
7149575, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous cardiac stimulator device having an anteriorly positioned electrode |
7181274, | Sep 18 2000 | Cameron Health, Inc. | Methods for inducing fibrillation utilizing subcutaneous electrodes |
7191009, | Aug 09 2004 | Medtronic, Inc. | Means for increasing implantable medical device electrode surface area |
7194302, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous cardiac stimulator with small contact surface electrodes |
7194309, | Sep 18 2000 | CAMERON HEALTH, INC | Packaging technology for non-transvenous cardioverter/defibrillator devices |
7239925, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with improved installation characteristics |
7248921, | Jun 02 2003 | CAMERON HEALTH, INC | Method and devices for performing cardiac waveform appraisal |
7274962, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode with improved contact shape for transthoracic conduction |
7299092, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with low profile installation appendage |
7299097, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with insertion tool |
7302300, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with highly maneuverable insertion tool |
7330757, | Nov 21 2001 | CAMERON HEALTH, INC | Method for discriminating between ventricular and supraventricular arrhythmias |
7349736, | Sep 18 2000 | CAMERON HEALTH, INC | Active housing dual lead assembly |
7359754, | Sep 18 2000 | Cameron Health, Inc. | Optional use of a lead for a unitary subcutaneous implantable cardioverter-defibrillator |
7363083, | Sep 18 2000 | Cameron Health, Inc. | Flexible subcutaneous implantable cardioverter-defibrillator |
7376458, | Nov 29 2004 | CAMERON HEALTH, INC | Method for defining signal templates in implantable cardiac devices |
7379772, | Nov 21 2001 | Cameron Health, Inc. | Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator |
7392085, | Nov 21 2001 | CAMERON HEALTH, INC | Multiple electrode vectors for implantable cardiac treatment devices |
7406350, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead |
7428437, | Sep 18 2000 | Cameron Health, Inc. | Canister designs for implantable cardioverter-defibrillators |
7444182, | Nov 21 2001 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
7463924, | Sep 18 2000 | Cameron Health, Inc. | Methods for determining placement of an implantable cardiac stimulus device |
7477935, | Nov 29 2004 | CAMERON HEALTH, INC | Method and apparatus for beat alignment and comparison |
7502645, | Sep 18 2000 | Cameron Health, Inc. | Current waveforms for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
7536222, | Sep 18 2000 | Cameron Health, Inc. | Nonvascular implantable defibrillator and method |
7555338, | Apr 26 2005 | CAMERON HEALTH, INC | Methods and implantable devices for inducing fibrillation by alternating constant current |
7616997, | Sep 27 2000 | CVRX, INC | Devices and methods for cardiovascular reflex control via coupled electrodes |
7623909, | May 26 2006 | Cameron Health, Inc.; CAMERON HEALTH, INC | Implantable medical devices and programmers adapted for sensing vector selection |
7623913, | Aug 01 2006 | Cameron Health, Inc.; CAMERON HEALTH, INC | Implantable medical devices using heuristic filtering in cardiac event detection |
7623916, | Dec 20 2006 | CAMERON HEALTH, INC | Implantable cardiac stimulus devices and methods with input recharge circuitry |
7623920, | Nov 05 2001 | Cameron Health, Inc. | Low power A/D converter |
7627367, | Nov 21 2001 | Cameron Health, Inc. | Multiple electrode vectors for implantable cardiac treatment devices |
7627375, | Sep 18 2000 | Cameron Health, Inc. | Implantable cardiac stimulus methods |
7650188, | Aug 09 2004 | Medtronic, Inc | Means for augmenting medical electrical systems |
7655014, | Dec 06 2004 | CAMERON HEALTH, INC | Apparatus and method for subcutaneous electrode insertion |
7657311, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous only implantable cardioverter-defibrillator and optional pacer |
7657322, | Sep 18 2000 | Cameron Health, Inc. | Subcutaneous electrode with improved contact shape for transthoracic conduction |
7720534, | Sep 18 2000 | Cameron Health, Inc. | Transthoracic impedance measurement in a subcutaneous device |
7720536, | Sep 18 2000 | Cameron Health, Inc. | Power supply for an implantable subcutaneous cardioverter-defibrillator |
7751885, | Sep 18 2000 | Cameron Health, Inc. | Bradycardia pacing in a subcutaneous device |
7774058, | Sep 18 2000 | CAMERON HEALTH, INC | Anterior positioning on opposing sides of sternum |
7774059, | Sep 18 2000 | CAMERON HEALTH, INC | Anterior positioning inactive housing |
7783340, | Jan 16 2007 | CAMERON HEALTH,INC | Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach |
7813797, | Sep 18 2000 | Cameron Health, Inc. | Cardioverter-defibrillator having a focused shocking area and orientation thereof |
7813812, | Sep 27 2000 | CVRX, INC | Baroreflex stimulator with integrated pressure sensor |
7835790, | Sep 18 2000 | CAMERON HEALTH, INC | Anterior active housing subcutaneous positioning methods |
7840271, | Sep 27 2000 | CVRx, Inc. | Stimulus regimens for cardiovascular reflex control |
7877139, | Sep 22 2006 | Cameron Health, Inc. | Method and device for implantable cardiac stimulus device lead impedance measurement |
7949400, | Sep 27 2000 | CVRX, INC | Devices and methods for cardiovascular reflex control via coupled electrodes |
7991459, | Nov 29 2004 | Cameron Health, Inc. | Method for defining signal templates in implantable cardiac devices |
8014851, | Sep 26 2006 | Cameron Health, Inc. | Signal analysis in implantable cardiac treatment devices |
8014862, | Sep 18 2000 | CAMERON HEALTH, INC | Anterior active housing subcutaneous positioning methods |
8060206, | Sep 27 2000 | CVRX, INC | Baroreflex modulation to gradually decrease blood pressure |
8086314, | Sep 27 2000 | CVRX, INC | Devices and methods for cardiovascular reflex control |
8116867, | Aug 04 2005 | Cameron Health, Inc. | Methods and devices for tachyarrhythmia sensing and high-pass filter bypass |
8160697, | Jan 25 2005 | CAMERON HEALTH, INC | Method for adapting charge initiation for an implantable cardioverter-defibrillator |
8160699, | Sep 18 2000 | Cameron Health, Inc. | Cardioverter-defibrillator having a focused shocking area and orientation thereof |
8200341, | Feb 07 2007 | CAMERON HEALTH, INC | Sensing vector selection in a cardiac stimulus device with postural assessment |
8224437, | Oct 22 2003 | CVRx, Inc. | Baroreflex activation for sedation and sleep |
8229563, | Jan 25 2005 | CAMERON HEALTH, INC | Devices for adapting charge initiation for an implantable cardioverter-defibrillator |
8290595, | Oct 29 2002 | CVRX, INC | Method and apparatus for stimulation of baroreceptors in pulmonary artery |
8412320, | Sep 18 2000 | Cameron Health, Inc. | Nontransvenous and nonepicardial methods of cardiac treatment and stimulus |
8447398, | Sep 18 2000 | CAMERON HEALTH, INC | Subcutaneous implantable cardioverter-defibrillator placement methods |
8478414, | Oct 22 2003 | CVRx, Inc. | Baroreflex activation for pain control, sedation and sleep |
8532767, | May 10 2011 | Biotronik SE & Co. KG | Device for medical applications and electromedical implant |
8560076, | Oct 22 2003 | CVRx, Inc. | Devices and methods for electrode implantation |
8583236, | Mar 27 2002 | CVRx, Inc. | Devices and methods for cardiovascular reflex control |
8606359, | Sep 27 2000 | CVRX, INC | System and method for sustained baroreflex stimulation |
8626285, | Jun 02 2003 | Cameron Health, Inc. | Method and devices for performing cardiac waveform appraisal |
8644956, | Jul 08 2008 | BIOTRONIK SE & CO KG | Shock electrode line |
8670826, | Jan 25 2005 | Cameron Health, Inc. | Methods and devices for adapting charge initiation for an implantable defibrillator |
8712531, | Sep 27 2000 | CVRx, Inc. | Automatic baroreflex modulation responsive to adverse event |
8718789, | Sep 27 2000 | CVRx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
8718793, | Aug 01 2006 | CAMERON HEALTH, INC | Electrode insertion tools, lead assemblies, kits and methods for placement of cardiac device electrodes |
8755907, | Oct 22 2003 | CVRx, Inc. | Devices and methods for electrode implantation |
8781602, | Feb 07 2007 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
8788023, | May 26 2006 | Cameron Health, Inc.; CAMERON HEALTH, INC | Systems and methods for sensing vector selection in an implantable medical device |
8838246, | Sep 27 2000 | CVRX, INC | Devices and methods for cardiovascular reflex treatments |
8880190, | Sep 27 2000 | CVRx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
8942802, | May 29 2003 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
8965530, | Feb 07 2007 | Cameron Health, Inc. | Implantable cardiac devices and methods using an x/y counter |
9022962, | Nov 22 2000 | Boston Scientific Scimed, Inc. | Apparatus for detecting and treating ventricular arrhythmia |
9044609, | Sep 27 2000 | CVRx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
9144683, | Sep 18 2000 | Cameron Health, Inc. | Post-shock treatment in a subcutaneous device |
9149645, | Mar 11 2013 | Cameron Health, Inc. | Methods and devices implementing dual criteria for arrhythmia detection |
9155485, | May 29 2003 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
9216284, | Aug 01 2006 | Cameron Health, Inc. | Electrode insertion tools, lead assemblies, kits and methods for placement of cardiac device electrodes |
9357969, | Feb 07 2007 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
9364677, | May 26 2006 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device |
9421390, | Mar 11 2013 | CAMERON HEALTH INC. | Methods and devices implementing dual criteria for arrhythmia detection |
9427583, | Sep 27 2000 | CVRx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
9555259, | May 29 2003 | CAMERON HEALTH INC. | Method for discriminating between ventricular and supraventricular arrhythmias |
9579065, | Mar 12 2013 | CAMERON HEALTH INC. | Cardiac signal vector selection with monophasic and biphasic shape consideration |
9744366, | Feb 07 2007 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
9844678, | Mar 11 2013 | Cameron Health, Inc. | Methods and devices implementing dual criteria for arrhythmia detection |
9968796, | May 29 2003 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
Patent | Priority | Assignee | Title |
3478746, | |||
3735766, | |||
3920888, | |||
4549548, | Sep 14 1983 | VITATRON MEDICAL B V , A CORP OF THE NETHERLANDS | Pacemaker system with automatic event-programmed switching between unipolar and bipolar operation |
5235978, | Mar 10 1992 | Pacesetter AB | Implantable arrangement for the defibrillation or cardioversion of a heart |
5241960, | Jul 08 1992 | ELA MEDICAL, S A | Defibrillator pulse generator |
5376103, | Mar 19 1992 | ELA MEDICAL, S A | Electrode system for implantable defibrillator |
5405363, | Mar 15 1991 | ELA MEDICAL, S A | Implantable cardioverter defibrillator having a smaller displacement volume |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 23 1995 | Angeion Corporation | (assignment on the face of the patent) | / | |||
Jan 18 1999 | Angeion Corporation | NORWEST BUSINESS CREDIT, INC | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 009693 | /0097 | |
Dec 02 1999 | NORWEST BUSINESS CREDIT, INC N K A WELLS FARGO BUSINESS CREDIT, INC | Angeion Corporation | RELEASE OF SECURITY INTEREST | 010470 | /0293 |
Date | Maintenance Fee Events |
Jan 25 2000 | REM: Maintenance Fee Reminder Mailed. |
Jul 02 2000 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Jul 02 1999 | 4 years fee payment window open |
Jan 02 2000 | 6 months grace period start (w surcharge) |
Jul 02 2000 | patent expiry (for year 4) |
Jul 02 2002 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 02 2003 | 8 years fee payment window open |
Jan 02 2004 | 6 months grace period start (w surcharge) |
Jul 02 2004 | patent expiry (for year 8) |
Jul 02 2006 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 02 2007 | 12 years fee payment window open |
Jan 02 2008 | 6 months grace period start (w surcharge) |
Jul 02 2008 | patent expiry (for year 12) |
Jul 02 2010 | 2 years to revive unintentionally abandoned end. (for year 12) |